Both in Pharmaceuticals
Biohaven vs Septerna
Over the past year BHVN returned −10.9% and SEPN returned +85.8%; their daily moves had a correlation of 0.23.
BHVN −10.9% SEPN +85.8%Growth of $1, one year, split-adjusted
| Metric | BHVN | SEPN |
|---|---|---|
| Price | $14.69 | $40.88 |
| Market cap | $2.22B | $1.91B |
| Today | +25.02% | +0.29% |
| 1 month | +7.5% | +6.3% |
| 6 months | +39.6% | +63.7% |
| Year to date | +30.1% | +46.6% |
| 1 year | −17.1% | +91.8% |
| Revenue growth (YoY) | — | +22375.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −48.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 19.3× |
| Net cash | $8.4M | $372.3M |
| Dividend yield | — | — |
| Volatility (60d) | 88.3% | 64.7% |
| Short % of float | 15.9% | 10.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).